About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
642 genotypes with 709 annotations displayed of selected term and subterms
Searched Term: increased adenocarcinoma incidence
Allelic Composition
(Genetic Background)		 Annotated Term Reference
A4gnttm1Jnaka/A4gnttm1Jnaka
(B6.129S6-A4gnttm1Jnaka) 		increased gastric adenocarcinoma incidence J:184485
Abraxas1tm1.1Bwng/Abraxas1+
(involves: 129S6/SvEvTac * C57BL/6NCrl * FVB/N) 		increased lung adenocarcinoma incidence J:269823
Acp3tm1Pivi/Acp3tm1Pivi
(B6.Cg-Acp3tm1Pivi) 		increased prostate gland adenocarcinoma incidence J:207558
Actbtm1(PyVT)Arge/Actb+
(involves: 129S1/Sv) 		increased mammary adenocarcinoma incidence J:87544
Actbtm1(PyVT)Arge/Actb+
Waptm1(cre)Arge/Wap+
(involves: 129S1/Sv) 		increased mammary adenocarcinoma incidence J:87544
Akt1Gt1Pnt/Akt1Gt1Pnt
Tg(MMTV-Erbb2)NK1Mul/Tg(MMTV-Erbb2)NK1Mul
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
Akt1Gt1Pnt/Akt1Gt1Pnt
Tg(MMTV-PyVT)634Mul/0
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Tg(MMTV-Erbb2)NK1Mul/Tg(MMTV-Erbb2)NK1Mul
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Tg(MMTV-PyVT)634Mul/0
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
Akt3tm1Mbb/Akt3tm1Mbb
Tg(MMTV-Erbb2)NK1Mul/Tg(MMTV-Erbb2)NK1Mul
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
Akt3tm1Mbb/Akt3tm1Mbb
Tg(MMTV-PyVT)634Mul/0
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
ApcM1Tno/Apc+
(either: B6JJcl.B6(D2JJcl)-ApcM1Tno or (involves: C57BL/6 * C57BL/6JJcl * DBA/2JJcl)) 		increased mammary adenocarcinoma incidence J:218227
ApcMin/Apc+
(involves: AKR/J * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:10209
ApcMin/Apc+
(involves: C57BL/6J) 		increased mammary adenocarcinoma incidence J:94108
ApcMin/Apc+
(B6(AKR)-ApcMin) 		increased intestinal adenocarcinoma incidence J:10209
ApcMin/Apc+
((AKR/J x C57BL/6J-ApcMin)F1) 		increased intestinal adenocarcinoma incidence J:21369
ApcMin/Apc+
Ccdc80tm1.1Ftk/Ccdc80tm1.1Ftk
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * C57BL/6J * C57BL/6N) 		increased colon adenocarcinoma incidence J:216704
ApcMin/Apc+
Hdac2Gt(W035F03)Joe/Hdac2Gt(W035F03)Joe
(involves: 129S2/SvPas * C57BL/6J) 		increased small intestine adenocarcinoma incidence J:152134
ApcMin/Apc+
Ppardtm1Jps/Ppardtm1Jps
(involves: 129/Sv * AKR/J * C57BL/6 * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:90337
ApcMin/Apc+
Spata18tm1.2Hifa/Spata18+
(involves: C57BL/6J) 		increased colon adenocarcinoma incidence J:254117
increased intestinal adenocarcinoma incidence J:254117
increased small intestine adenocarcinoma incidence J:254117
ApcMin/Apc+
Spata18tm1.2Hifa/Spata18tm1.2Hifa
(involves: C57BL/6J) 		increased colon adenocarcinoma incidence J:254117
increased intestinal adenocarcinoma incidence J:254117
increased small intestine adenocarcinoma incidence J:254117
ApcMin/Apc+
Tcf7tm1Cle/Tcf7tm1Cle
(involves: 129P2/OlaHsd * C57BL/6J) 		increased mammary adenoacanthoma incidence J:57721
ApcMin/Apc+
Tgfbr1tm1Bopa/Tgfbr1+
(involves: 129S1/SvImJ * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:143706
ApcMin/Apc+
Tgfbr1tm1Bopa/Tgfbr1+
(B6.Cg-Tgfbr1tm1Bopa ApcMin) 		increased intestinal adenocarcinoma incidence J:143706
ApcMin/Apc+
Trp53tm1Mlh/Trp53tm1Mlh
(involves: 129P2/OlaHsd * C57BL/6 * SWR) 		increased pancreatic acinar cell carcinoma incidence J:29664
Apctm1.1Rsmi/Apc+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased large intestine adenocarcinoma incidence J:159883
increased small intestine adenocarcinoma incidence J:159883
Apctm1Cip/Apc+
(involves: 129P2/OlaHsd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:94108
increased mammary adenocarcinoma incidence J:94108
Apctm1Cip/Apc+
H19tm1Lda/H19+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA) 		increased intestinal adenocarcinoma incidence J:138826
Apctm1Hsa/Apc+
(involves: 129P2/OlaHsd * C57BL/6) 		increased mammary adenocarcinoma incidence J:61978
Apctm1Mmt/Apc+
Smad4tm1Mmt/Smad4+
(involves: 129S2/SvPas * C57BL/6) 		increased intestinal adenocarcinoma incidence J:46242
increased pancreatic ductal adenocarcinoma incidence J:46242
Apctm1Rak/Apc+
(involves: 129P2/OlaHsd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:20443
Apctm1Rak/Apc+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:65142
Apctm1Rak/Apc+
Cdh1tm1Cbm/Cdh1+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:65142
Apctm1Rak/Apc+
Dcctm1.1Mehl/Dcctm1.1Mehl
(involves: 129P2/OlaHsd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:181517
Apctm1Rak/Apc+
Mlh1tm1Rak/Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6) 		increased adenocarcinoma incidence J:53451
Apctm1Rak/Apc+
Smad4E6sad/Smad4+
(B6.129P2-Apctm1Rak +/+ Smad4E6sad) 		increased intestinal adenocarcinoma incidence J:107273
Apctm1Rsmi/Apc+
Tg(Fabp1-cre)1Jig/0
(involves: 129P2/OlaHsd * FVB/N) 		increased intestinal adenocarcinoma incidence J:159883
increased large intestine adenocarcinoma incidence J:159883
increased small intestine adenocarcinoma incidence J:159883
Apctm1Tno/Apc+
Brf1tm1Arte/Brf1tm1Arte
Tg(Cyp1a1-cre)1Dwi/0
(involves: C57BL/6 * CBA) 		increased pancreatic ductal adenocarcinoma incidence J:285667
Apctm1Tno/Apc+
Ptentm2Mak/Ptentm2Mak
Tg(Cyp1a1-cre/ERT)1Dwi/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CBA) 		increased intestinal adenocarcinoma incidence J:143082
Apctm1Tno/Apc+
Tg(CDX2-cre)101Erf/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:126018
Apctm1Tno/Apc+
Tg(Vil1-cre)997Gum/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		increased small intestine adenocarcinoma incidence J:126018
Apctm1Tno/Apctm1Tno
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA/2) 		increased prostate gland adenocarcinoma incidence J:120308
Apctm2.1Cip/Apc+
Krastm4Tyj/Kras+
Tg(Fabp1-cre)1Jig/0
(involves: 129P2/OlaHsd * 129S4/SvJae * FVB) 		increased intestinal adenocarcinoma incidence J:132357
Apctm2.1Cip/Apc+
Tg(Fabp1-cre)1Jig/0
(involves: 129P2/OlaHsd * FVB/N) 		increased intestinal adenocarcinoma incidence J:132357
Apctm2Rak/Apctm2Rak
Krastm4Tyj/Kras+
(involves: 129 * 129S4/SvJae * C57BL/6J * SJL) 		increased adenocarcinoma incidence J:156532
Apctm2Rfo/Apc+
(B6.129P2-Apctm2Rfo) 		increased mammary adenocarcinoma incidence J:151494
Apctm2Rfo/Apc+
((C57BL/6J x 129P2/OlaHsd)F1) 		increased mammary adenocarcinoma incidence J:204440, J:151494
Apctm2Rfo/Apc+
(129P2/OlaHsd-Apctm2Rfo) 		increased mammary adenocarcinoma incidence J:151494
Apctm2Rfo/Apc+
Smad4E6sad/Smad4+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased mammary adenocarcinoma incidence J:151494
Artm1Verh/Y
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:172730
Atad5Gt(RRF055)Byg/Atad5+
(involves: 129P2/OlaHsd) 		increased liver adenocarcinoma incidence J:176672
increased lung adenocarcinoma incidence J:176672
Aurkbtm1.2Mama/Aurkb+
(involves: 129/Sv * BALB/cJ * C57BL/6 * CD-1 * SJL) 		increased adenocarcinoma incidence J:173575
increased liver adenocarcinoma incidence J:173575
B2mtm1Unc/B2mtm1Unc
Il2tm1Hor/Il2tm1Hor
(involves: 129 * C57BL/6) 		increased intestinal adenocarcinoma incidence J:51450
B3gnt6tm1Lx/B3gnt6tm1Lx
(involves: 129S1/Sv * C57BL/6J) 		increased adenocarcinoma incidence J:123826
B3gnt6tm1Lx/B3gnt6tm1Lx
C1galt1tm1.1Rpmc/C1galt1tm1.1Rpmc
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2) 		increased duodenum adenocarcinoma incidence J:239765
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm2Sjk
Krastm4Tyj/Kras+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		increased adenocarcinoma incidence J:125101
Bap1em1Test/Bap1+
(involves: FVB) 		increased mammary adenocarcinoma incidence J:231692
Bap1em2Test/Bap1+
(involves: FVB) 		increased mammary adenocarcinoma incidence J:231692
Bap1em3Test/Bap1+
(involves: FVB) 		increased mammary adenocarcinoma incidence J:231692
Bard1tm1Thl/Bard1tm2Thl
Waptm1(cre)Arge/0
(involves: 129S1/Sv * C57BL/6J) 		increased mammary adenocarcinoma incidence J:134977
Bard1tm2Thl/Bard1tm2Thl
Brca1tm1Thl/Brca1tm1Thl
Waptm1(cre)Arge/0
(involves: 129/Sv * 129S1/Sv * C57BL/6J) 		increased mammary adenocarcinoma incidence J:134977
Bard1tm2Thl/Bard1tm2Thl
Waptm1(cre)Arge/0
(involves: 129/Sv * 129S1/Sv * C57BL/6J) 		increased mammary adenocarcinoma incidence J:134977
Becn1tm1Blev/Becn1+
(involves: 129X1/SvJ * C57BL/6J) 		increased lung adenocarcinoma incidence J:86953
Becn1tm1Htz/Becn1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lung adenocarcinoma incidence J:86982
Bhlha15tm2(Kras)Skz/Bhlha15+
(involves: 129S6/SvEvTac * C57BL/6) 		increased pancreatic acinar cell carcinoma incidence J:105076
Bin1tm1Gcp/Bin1tm2Gcp
Tg(MMTV-Myc)141-3Led/0
Tg(Wap-cre)11738Mam/0
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N * SJL) 		increased mammary adenocarcinoma incidence J:117330
Bin3tm1Gcp/Bin3tm1Gcp
(involves: 129 * C57BL/6) 		increased lung adenocarcinoma incidence J:133313
Blmtm1Ches/Blmtm4Ches
Tg(LGB-cre)74Acl/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL) 		increased mammary adenocarcinoma incidence J:112115
Braftm1Mmcm/Braf+
(involves: 129P2/OlaHsd) 		increased lung adenocarcinoma incidence J:121715
Braftm1Mmcm/Braf+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd) 		increased lung adenocarcinoma incidence J:121715
Braftm1Mmcm/Braftm1Mmcm
Nkx3-1tm4(cre/ERT2)Mms/Nkx3-1+
Ptentm1Hwu/Pten+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:191327
Brca1tm1Aash/Brca1tm1Aash
Tg(LGB-cre)74Acl/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		increased salivary adenocarcinoma incidence J:119996
Brca1tm1Aash/Brca1tm1Aash
Trp53tm1Brd/Trp53+
Tg(LGB-cre)74Acl/0
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6 * CBA) 		increased salivary adenocarcinoma incidence J:119996
Brca1tm1Arge/Brca1tm1Thl
Waptm1(cre)Arge/0
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J) 		increased mammary adenocarcinoma incidence J:134977
Brca1tm1Bhk/Brca1+
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
(C.129-Cdkn2ctm1Yxi Brca1tm1Bhk) 		increased mammary adenocarcinoma incidence J:198018
Brca1tm1Cxd/Brca1tm2Cxd
Tg(MMTV-cre)4Mam/0
(involves: 129S6/SvEvTac * Black Swiss * FVB) 		increased mammary adenocarcinoma incidence J:54533
Brca1tm1Thl/Brca1tm1Thl
Waptm1(cre)Arge/0
(involves: 129S1/Sv * C57BL/6J) 		increased mammary adenocarcinoma incidence J:134977
Brca1tm2Mak/Brca1tm2Mak
Chek2tm1Mak/Chek2tm1Mak
Tg(Wap-cre)11738Mam/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL) 		increased mammary adenocarcinoma incidence J:90512
Brca1tm2Mak/Brca1tm2Mak
Trp53tm1Brd/Trp53+
Tg(Wap-cre)11738Mam/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL) 		increased mammary adenocarcinoma incidence J:90512
Brca2tm1Arge/Brca2tm2Arge
Waptm1(cre)Arge/Wap+
(involves: 129S/SvEv * C57BL/6) 		increased mammary adenocarcinoma incidence J:70564
Brca2tm1Brn/Brca2+
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:73028
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Brn/Trp53+
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:73028
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:73028
Brca2tm1Brn/Brca2tm1Cam
Krastm4Tyj/Kras+
Trp53tm3Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic acinar cell carcinoma incidence J:166678
increased pancreatic ductal adenocarcinoma incidence J:166678
Brca2tm1Cam/Brca2+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:166678
Brca2tm1Cam/Brca2+
Krastm4Tyj/Kras+
Trp53tm3Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:166678
Brca2tm1Cam/Brca2tm1Brn
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:166678
Brca2tm2Arge/Brca2tm2Arge
Waptm1(cre)Arge/Waptm1(cre)Arge
(involves: 129S1/Sv * C57BL/6) 		increased mammary adenocarcinoma incidence J:70564
Brf1tm1Arte/Brf1tm1Arte
Krastm4Tyj/Kras+
Trp53tm2Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * 129S7/SvEvBrd * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:285667
Brip1Gt(RRI409)Byg/Brip1Gt(RRI409)Byg
(involves: 129P2/OlaHsd) 		increased adenocarcinoma incidence J:227115
Bub1bGt(neo-btk)1Dai/Bub1b+
(involves: 129S4/SvJae) 		increased intestinal adenocarcinoma incidence J:88094
Bub1btm1.1Hsl/Bub1b+
(involves: 129 * C57BL/6) 		increased adenocarcinoma incidence J:201641
increased lung adenocarcinoma incidence J:201641
increased rectum adenocarcinoma incidence J:201641
Ccn6tm1.1Cgkl/Ccn6tm1.1Cgkl
Tg(MMTV-cre)1Mam/0
(FVB/N-Ccn6tm1.1Cgkl Tg(MMTV-cre)1Mam) 		increased mammary adenocarcinoma incidence J:241259
Ccn6tm1.1Cgkl/Ccn6tm1.1Cgkl
Tg(MMTV-cre)1Mam/0
Tg(MMTV-PyVT)634Mul/0
(FVB/N-Ccn6tm1.1Cgkl Tg(MMTV-cre)1Mam Tg(MMTV-PyVT)634Mul) 		increased mammary adenocarcinoma incidence J:241259
Ccnd1tm4Pisc/Ccnd1tm4Pisc
Tg(MMTV-Erbb2)NK1Mul/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:156591
Cdh1tm1Jjon/Cdh1+
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:116152
Cdh1tm1Jjon/Cdh1+
Trp53tm1Brn/Trp53tm1Brn
Tg(Wap-cre)51Nki/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:171765
Cdh1tm1Jjon/Cdh1tm1Jjon
Trp53tm1Brn/Trp53+
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:116152
Cdh1tm1Jjon/Cdh1tm1Jjon
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:116152
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)7Mul/0
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:212549
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)6Tuv/0
(involves: 129 * C57BL/6 * FVB/N) 		increased duodenum adenocarcinoma incidence J:212549
increased gastric adenocarcinoma incidence J:212549
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(Vil1-cre)20Syr/0
(involves: 129 * C57BL/6 * DBA/2) 		increased intestinal adenocarcinoma incidence J:212549
Cdh1tm2Kem/Cdh1tm2Kem
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)6Tuv/0
(involves: 129 * C57BL/6 * FVB/N) 		increased gastric adenocarcinoma incidence J:212549
Cdk4tm2.1Bbd/Cdk4tm2.1Bbd
Krastm1Bbd/Krastm2Bbd
Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ) 		increased adenocarcinoma incidence J:161780
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Tg(MMTV-vHaras)SH1Led/0
(involves: 129S2/SvPas * C57BL/6J * CD-1 * FVB/N) 		increased mammary adenocarcinoma incidence J:66183
increased salivary adenocarcinoma incidence J:66183
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv) 		increased lung adenocarcinoma incidence J:120835
Cdkn2atm1.1Gsu/Cdkn2atm1.1Gsu
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N) 		increased adenocarcinoma incidence J:198619
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Sclt1Tg(CAG-sb10)1Dla/0
TgTn(sb-T2/Onc)68Dla/0
(involves: 129X1/SvJ * FVB/N) 		increased lung adenocarcinoma incidence J:99991
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Sclt1Tg(CAG-sb10)1Dla/0
TgTn(sb-T2/Onc)76Dla/0
(involves: 129X1/SvJ * FVB/N) 		increased lung adenocarcinoma incidence J:99991
Cdkn2atm1Rdp/Cdkn2a+
Tg(CAG-Bgeo,-tTA,-EGFP)2A11Kuw/0
Tg(Pdx1-cre)6Tuv/0
Tg(tetO-MYC)36Bop/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * FVB/N * SJL) 		increased pancreatic ductal adenocarcinoma incidence J:197052
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Krastm4Tyj/Kras+
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * FVB/N * SJL) 		increased lung adenocarcinoma incidence J:124682
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-Kras2)12Hev/0
(involves: 129 * C57BL/6J * FVB/N * SJL) 		increased lung adenocarcinoma incidence J:166963, J:73468
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(tetO-BRAF*V600E)29Lc/0
Tg(Tyr-rtTA)37Lc/0
(involves: 129/Sv * C57BL/6J * SJL) 		increased prostate gland adenocarcinoma incidence J:144358
Cdkn2atm2.1Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:108298
Cdkn2atm2.1Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:108298
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:124682
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N) 		increased adenocarcinoma incidence J:198619
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:108298
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:108298
Cdkn2atm4Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Cdkn2atm4Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Smad4tm1Rdp/Smad4tm1Rdp
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Cdkn2atm4Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Smad4tm1Rdp/Smad4tm1Rdp
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Cdkn2atm4Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Cdkn2atm4Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:108298
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Krastm4Tyj/Kras+
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:195492
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Krastm4Tyj/Kras+
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Krastm4Tyj/Kras+
Smad4tm1Rdp/Smad4tm1Rdp
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Krastm4Tyj/Kras+
Smad4tm1Rdp/Smad4tm1Rdp
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:116130, J:108298, J:87196
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		increased pancreatic ductal adenocarcinoma incidence J:187012
Cdkn2btm1Bbd/Cdkn2btm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased adenocarcinoma incidence J:63299
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
(B6.129-Cdkn2ctm1Yxi) 		increased lung adenocarcinoma incidence J:120835
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
Men1tm1.1Ctre/Men1+
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6) 		increased adenocarcinoma incidence J:120835
increased lung adenocarcinoma incidence J:120835
Chek1tm1Sje/Chek1+
Tg(Wnt1)1Hev/0
(Not Specified) 		increased mammary adenocarcinoma incidence J:62919
Chek1tm2.1Sje/Chek1+
Trp53tm1Brn/Trp53+
Tg(MMTV-cre)#Mam/0
(involves: 129P2/OlaHsd * FVB) 		increased mammary adenocarcinoma incidence J:162126
Col1a1tm1(CAG-EGFR*T790M*C797S*L858R)Mje/Col1a1+
(involves: 129S4/SvJae * BALB/c * C57BL/6) 		increased lung adenocarcinoma incidence J:235747
Col1a1tm1(tetO-YAP1*)Fcam/Col1a1+
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:222916
Col1a1tm4(CAG-FGFR2_iIIIb*K660N)Kkw/Col1a1+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6) 		increased lung adenocarcinoma incidence J:214230
Cop1tm2.1Vmd/Cop1+
Tg(Pbsn-cre)4Prb/0
(B6N.CgCop1tm2.1Vmd Ptentm1Hwu Tg(Pbsn-cre)4Prb) 		increased prostate gland adenocarcinoma incidence J:172653
Ctnnb1tm1.2Wvv/Ctnnb1+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:185942
Ctnnb1tm1Mmt/Ctnnb1+
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Prom1tm1(cre/ERT2)Gilb/Prom1+
(involves: 129S6/SvEvTac * 129X1/SvJ) 		increased intestinal adenocarcinoma incidence J:144215
Ctnnb1tm1Mmt/Ctnnb1+
Igs2tm1(CAG-Met)Zsu/Igs2+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2 * FVB/N) 		increased prostate gland adenocarcinoma incidence J:284956
Ctnnb1tm1Mmt/Ctnnb1+
Tg(Pbsn-cre)4Prb/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:143034, J:284956
Dcctm1.1Mehl/Dcctm1.1Mehl
(Not Specified) 		increased intestinal adenocarcinoma incidence J:181517
Dcctm1Nki/Dcctm1Nki
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/?
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:181090
Del(4Cdkn2a-Cdkn2b)2Brn/+
(involves: 129P2/OlaHsd * FVB/N) 		increased intestinal adenocarcinoma incidence J:125189
Del(15Krt7-Krt18)1Tmm/+
Igs11tm1Tmm/Igs11+
Krt1ctm1Tmm/Krt1c+
Tg(ACTB-KRAS*G12V,-luc)#Lche/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:199528
Diras2em1Gpt/Diras2em1Gpt
Krastm4Tyj/Kras+
Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129S4/SvJae * C57BL/6J * C57BL/6JGpt) 		increased pancreatic ductal adenocarcinoma incidence J:348744
Dkc1tm1Ppp/Y
(involves: 129S1/Sv) 		increased mammary adenocarcinoma incidence J:81054
Dmtf1tm1Cjs/Dmtf1+
Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased lung adenocarcinoma incidence J:126002
Dmtf1tm1Cjs/Dmtf1+
Krastm3Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased lung adenocarcinoma incidence J:126002
Dmtf1tm1Cjs/Dmtf1tm1Cjs
Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased lung adenocarcinoma incidence J:126002
Dmtf1tm1Cjs/Dmtf1tm1Cjs
Krastm3Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased lung adenocarcinoma incidence J:126002
Dna2tm1.1Lzhg/Dna2+
(involves: 129S1/Sv) 		increased lung adenocarcinoma incidence J:198831
Dnai7Gt(VICTR21)709Lex/Dnai7+
(involves: 129S5/SvEvBrd) 		increased lung adenocarcinoma incidence J:111629
Dnai7Gt(VICTR21)709Lex/Dnai7Gt(VICTR21)709Lex
(involves: 129S5/SvEvBrd) 		increased lung adenocarcinoma incidence J:111629
Dnmt1tm1Jae/Dnmt1+
Mlh1tm1Lisk/Mlh1tm1Lisk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:75745
Dnmt1tm1Pwl/Dnmt1+
Mlh1tm1Lisk/Mlh1tm1Lisk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:75745
Dock1tm2.1Jfco/Dock1+
Tg(MMTV-Erbb2*,-cre)1Mul/0
(involves: C57BL/6 * FVB/NJ) 		increased mammary adenocarcinoma incidence J:196659
Dock1tm2.1Jfco/Dock1tm2.1Jfco
Tg(MMTV-Erbb2*,-cre)1Mul/0
(involves: C57BL/6 * FVB/NJ) 		increased mammary adenocarcinoma incidence J:196659
Dok1tm1Ppp/Dok1tm1Ppp
(129S1/Sv-Dok1tm1Ppp) 		increased lung adenocarcinoma incidence J:158011
Dok1tm1Ppp/Dok1tm1Ppp
Dok2tm1Ppp/Dok2tm1Ppp
(129S1/Sv-Dok1tm1Ppp Dok2tm1Ppp) 		increased lung adenocarcinoma incidence J:158011
Dok1tm1Ppp/Dok1tm1Ppp
Dok2tm1Ppp/Dok2tm1Ppp
Dok3tm1Ppp/Dok3tm1Ppp
(129S1/Sv-Dok1tm1Ppp Dok2tm1Ppp Dok3tm1Ppp) 		increased lung adenocarcinoma incidence J:158011
Dok1tm1Ppp/Dok1tm1Ppp
Dok3tm1Ppp/Dok3tm1Ppp
(129S1/Sv-Dok1tm1Ppp Dok3tm1Ppp) 		increased lung adenocarcinoma incidence J:158011
Dok2tm1Ppp/Dok2tm1Ppp
(129S1/Sv-Dok2tm1Ppp) 		increased lung adenocarcinoma incidence J:158011
Dok3tm1Ppp/Dok3tm1Ppp
(129S1/Sv-Dok3tm1Ppp) 		increased lung adenocarcinoma incidence J:158011
E2f1tm1Njd/E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6) 		increased lung adenocarcinoma incidence J:33099
Eaf2tm1Zhow/Eaf2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lung adenocarcinoma incidence J:145228
Eaf2tm1Zhow/Eaf2tm1Zhow
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lung adenocarcinoma incidence J:145228
Eef1a1tm1(Kras*)Arge/Eef1a1+
Waptm1(cre)Arge/Wap+
(involves: 129S1/Sv) 		increased mammary adenocarcinoma incidence J:146290
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon
Lyz2tm1(cre)Ifo/Lyz2+
(B6.129P2-Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo) 		increased colon adenocarcinoma incidence J:184388
Ergtm1.1Sho/Ergtm1.1Sho
Ptentm1Hwu/Ptentm1Hwu
Tmprss2tm3Sho/Tmprss2tm3Sho
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:212219
Esr1tm1Ksk/Esr1tm1Ksk
Tg(Wnt1)1Hev/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:54215
F2rtm1Pago/F2rtm1Pago
Tg(MMTV-PyVT)634Mul/0
(B6.Cg-F2rtm1Pago Tg(MMTV-PyVT)634Mul) 		increased mammary adenocarcinoma incidence J:138924
F2rl1tm1Bpd/F2rl1tm1Bpd
Tg(MMTV-PyVT)634Mul/0
(B6.Cg-F2rl1tm1Bpd Tg(MMTV-PyVT)634Mul) 		increased mammary adenocarcinoma incidence J:138924
Fen1tm3.1Bhsh/Fen1tm3.1Bhsh
(Not Specified) 		increased lung adenocarcinoma incidence J:231218
Fgfr4tm1Axul/Fgfr4+
Tg(WapTgfa)215Bri/0
(B6.Cg-Fgfr4tm1Axul Tg(WapTgfa)215Bri) 		increased mammary adenocarcinoma incidence J:156750
Fgfr4tm1Axul/Fgfr4tm1Axul
Tg(WapTgfa)215Bri/0
(B6.Cg-Fgfr4tm1Axul Tg(WapTgfa)215Bri) 		increased mammary adenocarcinoma incidence J:156750
Fgfr4tm1Axul/Fgfr4tm1Axul
Tg(WapTgfa)215Bri/0
(FVB.Cg-Fgfr4tm1Axul Tg(WapTgfa)215Bri) 		increased mammary adenocarcinoma incidence J:156750
Fntbtm1Bbd/Fntbtm1Bbd
Krastm1Bbd/Kras+
Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL) 		increased lung adenocarcinoma incidence J:98944
Frmd3em1Zhaj/Frmd3em1Zhaj
Tg(MMTV-PyVT)634Mul/0
(B6.Cg-Frmd3em1Zhaj Tg(MMTV-PyVT)634Mul) 		increased mammary adenocarcinoma incidence J:350496
Fzr1tm1.1Mama/Fzr1+
(involves: BALB/cJ * C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:137456
Gadd45atm1Ajf/Gadd45atm1Ajf
Xpctm1Ecf/Xpctm1Ecf
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129X1/SvJ * C57BL/6)) 		increased lung adenocarcinoma incidence J:101421
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:24434
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd) 		increased intestinal adenocarcinoma incidence J:24434
Gon4ljusty/Gon4ljusty
(C3HeB/FeJ-Gon4ljusty) 		increased salivary adenocarcinoma incidence J:197352
Gprc5atm1Rlo/Gprc5atm1Rlo
(involves: 129 * C57BL/6) 		increased lung adenocarcinoma incidence J:127821
Gpx7tm1Whle/Gpx7tm1Whle
(involves: 129P2/OlaHsd * C57BL/6) 		increased lung adenocarcinoma incidence J:193993
increased mammary adenocarcinoma incidence J:193993
Grb2tm1Paw/Grb2+
Tg(MMTV-PyVT)634Mul/?
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased mammary adenocarcinoma incidence J:51424
Gt(ROSA)26Sortm1(CAG-AR)Zsu/Gt(ROSA)26Sor+
Tg(Osr1-cre)4Mrt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		increased prostate gland adenocarcinoma incidence J:234601
Gt(ROSA)26Sortm1(CAG-AR)Zsu/Gt(ROSA)26Sortm1(CAG-AR)Zsu
Tg(Osr1-cre)4Mrt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		increased prostate gland adenocarcinoma incidence J:234601
Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/Gt(ROSA)26Sor+
Ptentm1Mro/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N) 		increased prostate gland adenocarcinoma incidence J:184533
Gt(ROSA)26Sortm1(CAG-PIK3CA*H1047R,-EGFP)Balj/Gt(ROSA)26Sor+
Tg(MMTV-cre)7Mul/0
(involves: BALB/c * FVB/N) 		increased mammary adenocarcinoma incidence J:173655
Gt(ROSA)26Sortm1(CAG-PIK3CA*H1047R,-EGFP)Balj/Gt(ROSA)26Sor+
Tg(Wap-cre)1Gsc/0
(involves: BALB/c * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:173655
Gt(ROSA)26Sortm1(CAG-Sox2,-EGFP)Blh/Gt(ROSA)26Sor+
Tg(Sftpc-cre)1Blh/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		increased lung adenocarcinoma incidence J:161806
Gt(ROSA)26Sortm1(CAG-Sox2,-EGFP)Blh/Gt(ROSA)26Sortm1(CAG-Sox2,-EGFP)Blh
Scgb1a1tm1(cre/ERT)Blh/Scgb1a1+
(involves: 129S6/SvEv * C57BL/6) 		increased lung adenocarcinoma incidence J:161806
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129X1/SvJ * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:280854
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
Trp53tm1Brn/Trp53+
(involves: 129 * C57BL/6 * CBA) 		increased pancreatic ductal adenocarcinoma incidence J:289183
Gt(ROSA)26Sortm1(JAG1)Xin/Gt(ROSA)26Sor+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)20Fwan/?
(involves: 129S4/SvJae * C57BL/6 * FVB/NCrl) 		increased prostate gland adenocarcinoma incidence J:238768
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
Tg(MMTV-cre)#Tfln/0
(involves: 129S6/SvEvTac) 		increased mammary adenocarcinoma incidence J:170898
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
Tg(MMTV-cre)#Tfln/0
Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased mammary adenocarcinoma incidence J:170898
Gt(ROSA)26Sortm1(RAC1*)Jkis/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:187582
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Ptf1atm1.1(cre)Cvw/Ptf1a+
Tg(tetO-Kras2)12Hev/0
Trp53tm1Tyj/Trp53+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:184378
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Ptf1atm1.1(cre)Cvw/Ptf1a+
Tg(tetO-Kras*G12D)#Rdp/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:186194
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Ptf1atm1.1(cre)Cvw/Ptf1a+
Tg(tetO-Kras*G12D)#Rdp/0
Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:186194
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Ptf1atm1.1(cre)Cvw/Ptf1a+
Tg(tetO-Kras*G12D)#Rdp/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:186194
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
Hprt1tm1(sb-Onco-Array)Peli/Y
(involves: 129S7/SvEvBrd) 		increased lung adenocarcinoma incidence J:166283
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
Hprt1tm1(sb-Onco-Array)Peli/Hprt1+
(involves: 129S7/SvEvBrd) 		increased lung adenocarcinoma incidence J:166283
Gt(ROSA)26Sortm1(SPOP*F133V)Mrbn/Gt(ROSA)26Sor+
Ptentm2.1Ppp/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:239660
Gt(ROSA)26Sortm1(SPOP*F133V)Mrbn/Gt(ROSA)26Sor+
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:239660
Gt(ROSA)26Sortm1(TMPRSS2/ERG)Key/Gt(ROSA)26Sortm1(TMPRSS2/ERG)Key
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:200002
Gt(ROSA)26Sortm1(Tva)Dsa/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J) 		increased pancreatic ductal adenocarcinoma incidence J:140423
Gt(ROSA)26Sortm1(Tva)Dsa/Gt(ROSA)26Sor+
Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129S6/SvEvTac * C57BL/6J) 		increased pancreatic ductal adenocarcinoma incidence J:140423
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
Tg(RasE)290Biat/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased lung adenocarcinoma incidence J:226601
increased pancreatic ductal adenocarcinoma incidence J:226601
Gt(ROSA)26Sortm2(myc*T58A)Rcse/Gt(ROSA)26Sortm2(myc*T58A)Rcse
Tg(Wap-cre)11738Mam/0
(involves: 129 * C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:169403
Gt(ROSA)26Sortm2(Pik3ca*)Dsa/Gt(ROSA)26Sor+
Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129S6/SvEvTac) 		increased pancreatic ductal adenocarcinoma incidence J:197054
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
Tg(Vil1-cre)20Syr/0
TgTn(sb-T2/Onc)68Dla/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased small intestine adenocarcinoma incidence J:146887
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
Tg(Vil1-cre)20Syr/0
TgTn(sb-T2/Onc)76Dla/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased small intestine adenocarcinoma incidence J:146887
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Hmga2tm1.1Mmw/Hmga2+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm2Tyj/Trp53+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:245611
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Prdm1tm1Clme/Prdm1tm1Clme
Tg(Pdx1-cre)6Tuv/0
Trp53tm2Tyj/Trp53+
(involves: 129 * C57BL/6NCrl * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:245611
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm2Tyj/Trp53+
(involves: 129 * C57BL/6NCrl * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:245611
H2axtm1Fwa/H2axtm1Fwa
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased colon adenocarcinoma incidence J:84879
Hcktm1Ern/Hcktm1Ern
(involves: 129S1/Sv * C57BL/6) 		increased lung adenocarcinoma incidence J:111432
Hic1tm1Sbb/Hic1+
(involves: 129S4/SvJae * C57BL/6) 		increased lung adenocarcinoma incidence J:81448
Hprt1tm1(CAG-BRF1)Gu/Hprt1+
Krastm4Tyj/Kras+
Trp53tm2Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:285667
Hprt1tm1(CUX1)Anep/Hprt1+
(FVB.129P2-Hprt1tm1(CUX1)Anep) 		increased mammary adenocarcinoma incidence J:152682
Hprt1tm1(Pbsn*-cre/ERT2)Jir/Y
Ptentm2Mak/Ptentm2Mak
(involves: 129P2/OlaHsd * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:144357
Hprt1tm2(CUX1)Anep/Hprt1+
(FVB.129P2-Hprt1tm2(CUX1)Anep) 		increased mammary adenocarcinoma incidence J:152682
Hrastm2Xbr/Hrastm2Xbr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:137729
Hspa5tm1Alee/Hspa5+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/?
(involves: 129 * 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:142106
Htatip2tm1Hx/Htatip2tm1Hx
(involves: 129P2/OlaHsd * C57BL/6J) 		increased duodenum adenocarcinoma incidence J:87066
Ifngtm1Ts/Ifngtm1Ts
(C.129S7-Ifngtm1Ts) 		increased lung adenocarcinoma incidence J:77491
Igs2tm1(CAG-Met)Zsu/Igs2+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129 * C57BL/6 * DBA/2 * FVB/N) 		increased prostate gland adenocarcinoma incidence J:268934
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:68476
increased large intestine adenocarcinoma incidence J:35020
Il10tm1Cgn/Il10tm1Cgn
(B6.129P2-Il10tm1Cgn/J) 		increased colon adenocarcinoma incidence J:149347
Il10tm1Cgn/Il10tm1Cgn
Tg(MUC1)79.24Gend/0
(B6.Cg-Il10tm1Cgn Tg(MUC1)79.24Gend) 		increased colon adenocarcinoma incidence J:149347
Itgavtm2Hyn/Itgavtm2.1Hyn
Tg(Tek-cre)1Ywa/?
(involves: 129S2/SvPas * C57BL/6 * FVB * SJL) 		increased intestinal adenocarcinoma incidence J:125508
Krastm1.1Khai/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:276349
Krastm1Bbd/Kras+
Mapk14tm1Nbr/Mapk14tm2Nbr
Polr2atm1(cre/ERT2)Bbd/Polr2a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL) 		increased lung adenocarcinoma incidence J:122397
Krastm1Bbd/Kras+
Tg(CMV-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6) 		increased lung adenocarcinoma incidence J:86101
Krastm1Bbd/Kras+
Tg(CMV-cre/ERT)1Ipc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased lung adenocarcinoma incidence J:86101
Krastm1Bbd/Kras+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:143034
Krastm1Bbd/Kras+
Trp53tm1Brd/Trp53+
Tg(Cela1-tTA)#Eps/?
Tg(tetO-cre)3Jig/?
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:119988
Krastm1Bbd/Krastm1Bbd
Tg(Cela1-tTA)#Eps/?
Tg(tetO-cre)3Jig/?
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:119988
Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased lung adenocarcinoma incidence J:68981
Krastm2Tyj/Kras+
(involves: 129S2/SvPas) 		increased lung adenocarcinoma incidence J:136369
Krastm3Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased lung adenocarcinoma incidence J:68981
Krastm4Tyj/Kras+
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:207982, J:333347
Krastm4Tyj/Kras+
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:147590
Krastm4Tyj/Kras+
(B6.129S4-Krastm4Tyj) 		increased lung adenocarcinoma incidence J:177379
Krastm4Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:124682
Krastm4Tyj/Kras+
Gt(ROSA)26Sortm1(sb13)Tuv/Gt(ROSA)26Sor+
Tg(Pdx1-cre)6Tuv/0
TgTn(sb-T2/Onc)#Dla/0
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:186717
Krastm4Tyj/Kras+
Map2k7tm1.1Twad/Map2k7tm1.2Twad
(B6.Cg-Krastm4Tyj Map2k7tm1.1Twad/Map2k7tm1.2Twad) 		increased lung adenocarcinoma incidence J:170904
Krastm4Tyj/Kras+
Map2k7tm1.1Twad/Map2k7tm1.2Twad
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased lung adenocarcinoma incidence J:170904
Krastm4Tyj/Kras+
Pggt1btm1Mbrg/Pggt1b+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		increased lung adenocarcinoma incidence J:122107
Krastm4Tyj/Kras+
Ptentm1Hwu/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:184935
Krastm4Tyj/Kras+
Ptentm1Hwu/Pten+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * BALB/c * C57BL/6) 		increased pancreatic ductal adenocarcinoma incidence J:164210
Krastm4Tyj/Kras+
Ptentm1Hwu/Ptentm1Hwu
Scgb1a1tm1.1(cre)Fjd/Scgb1a1+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased lung adenocarcinoma incidence J:131721
Krastm4Tyj/Kras+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:184935
Krastm4Tyj/Kras+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA) 		increased pancreatic ductal adenocarcinoma incidence J:164210
Krastm4Tyj/Kras+
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased pancreatic ductal adenocarcinoma incidence J:116130, J:87973
Krastm4Tyj/Kras+
Ptf1atm1.1(cre)Cvw/Ptf1a+
(B6.129(Cg)-Krastm4Tyj Ptf1atm1.1(cre)Cvw) 		increased pancreatic ductal adenocarcinoma incidence J:138959
Krastm4Tyj/Kras+
Ptf1atm1.1(cre)Cvw/Ptf1a+
Tg(MUC1)79.24Gend/0
(B6.Cg-Krastm4Tyj Ptf1atm1.1(cre)Cvw Tg(MUC1)79.24Gend) 		increased pancreatic ductal adenocarcinoma incidence J:138959
Krastm4Tyj/Kras+
Raf1tm2Bacc/Raf1tm2Bacc
Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased pancreatic ductal adenocarcinoma incidence J:197054
Krastm4Tyj/Kras+
Rb1tm3Tyj/Rb1tm3Tyj
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:147590
Krastm4Tyj/Kras+
Rbl2tm2Tyj/Rbl2tm2Tyj
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:147590
Krastm4Tyj/Kras+
Rnf7Gt(XE423)Byg/Rnf7+
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased lung adenocarcinoma incidence J:207982
Krastm4Tyj/Kras+
Scgb1a1tm1(cre/ERT)Blh/Scgb1a1+
Trp53tm5Tyj/Trp53+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6) 		increased adenocarcinoma incidence J:182218
Krastm4Tyj/Kras+
Scribtm1.1Phum/Scrib+
Tg(Pbsn-cre)20Fwan/0
(involves: 129S4/SvJae * FVB/NCrl) 		increased prostate gland adenocarcinoma incidence J:178461
Krastm4Tyj/Kras+
Scribtm1.1Phum/Scribtm1.1Phum
Tg(Pbsn-cre)20Fwan/0
(involves: 129S4/SvJae * FVB/NCrl) 		increased prostate gland adenocarcinoma incidence J:178461
Krastm4Tyj/Kras+
Sftpctm1(cre/ERT2)Blh/Sftpc+
Trp53tm5Tyj/Trp53+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6) 		increased adenocarcinoma incidence J:182218
Krastm4Tyj/Kras+
Sftpctm1.1(cre/ERT2)Ptch/Sftpc+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB) 		increased lung adenocarcinoma incidence J:195738
Krastm4Tyj/Kras+
Smad4tm1Rdp/Smad4tm1Rdp
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:116130
Krastm4Tyj/Kras+
Stk11tm1.1Rdp/Stk11tm1.1Rdp
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:124682
Krastm4Tyj/Kras+
Stk11tm1.1Rdp/Stk11tm1.2Rdp
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:124682
Krastm4Tyj/Kras+
Tg(CAG-Bgeo,-tsA58T)T26Ichi/0
Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:214846
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/?
(involves: 129S4/SvJae * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:87973
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm1Gev/Trp53tm1Gev
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:220300
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:276349
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm3Tyj/Trp53+
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:166678
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		increased pancreatic ductal adenocarcinoma incidence J:116130, J:164210
Krastm4Tyj/Kras+
Tg(Scgb1a1-cre)1Kkw/?
(involves: 129 * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:107260
Krastm4Tyj/Kras+
Tgfbr2tm1.2Hlm/Tgfbr2+
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2) 		increased pancreatic ductal adenocarcinoma incidence J:116129
Krastm4Tyj/Kras+
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
(B6.129-Krastm4Tyj Tgfbr2tm1.2Hlm) 		increased lung adenocarcinoma incidence J:177379
Krastm4Tyj/Kras+
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2) 		increased pancreatic ductal adenocarcinoma incidence J:116129
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:108298
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased adenocarcinoma incidence J:103407
increased lung adenocarcinoma incidence J:195492, J:154041, J:103407
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:124682
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:108298
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm2Tyj
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased adenocarcinoma incidence J:103407
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm2Tyj
Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased pancreatic ductal adenocarcinoma incidence J:197054
Krastm4Tyj/Kras+
Trp53tm1Lejo/Trp53tm1Lejo
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:187012
Krastm4Tyj/Kras+
Trp53tm2Tyj/Trp53+
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:191425
Krastm4Tyj/Kras+
Trp53tm2Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:98936
Krastm5Tyj/Kras+
Pdx1tm1.1(flpo)Most/Pdx1+
Trp53tm1.1Dgk/Trp53+
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * Black Swiss * C57BL/6) 		increased pancreatic ductal adenocarcinoma incidence J:248550
Krastm5Tyj/Kras+
Pdx1tm1.1(flpo)Most/Pdx1+
Trp53tm1.1Dgk/Trp53tm1.1Dgk
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * Black Swiss * C57BL/6) 		increased pancreatic ductal adenocarcinoma incidence J:248550
Krastm5Tyj/Kras+
Trp53tm1.1Dgk/Trp53tm1.1Dgk
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		increased lung adenocarcinoma incidence J:180576
Lig1tm3Dwm/Lig1tm3Dwm
(involves: 129P2/OlaHsd * C57BL/6) 		increased adenocarcinoma incidence J:77902
Lig4tm2.1Fwa/Lig4tm2.1Fwa
(involves: 129S6/SvEvTac) 		increased colon adenocarcinoma incidence J:157574
Lmo7tm1Miyo/Lmo7+
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		increased lung adenocarcinoma incidence J:150612
Lmo7tm1Miyo/Lmo7+
(involves: 129X1/SvJ * C57BL/6) 		increased lung adenocarcinoma incidence J:150612
Lmo7tm1Miyo/Lmo7tm1Miyo
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		increased lung adenocarcinoma incidence J:150612
Lmo7tm1Miyo/Lmo7tm1Miyo
(involves: 129X1/SvJ * C57BL/6) 		increased lung adenocarcinoma incidence J:150612
Ltbp4Gt(U3Cre)1Vmel/Ltbp4Gt(U3Cre)1Vmel
(B6.129S2-Ltbp4Gt(U3Cre)1Vmel) 		increased large intestine adenocarcinoma incidence J:78819
Lzts1tm1Cro/Lzts1+
(involves: 129 * C57BL/6J) 		increased gastric adenocarcinoma incidence J:119989
Lzts1tm1Cro/Lzts1tm1Cro
(involves: 129 * C57BL/6J) 		increased gastric adenocarcinoma incidence J:119989
increased lung adenocarcinoma incidence J:119989
Mad1l1tm1.1Ktj/Mad1l1+
(involves: BALB/c * C57BL/6J) 		increased lung adenocarcinoma incidence J:117337
Mad2l1tm1Sorg/Mad2l1+
(involves: 129S2/SvPas * C57BL/6) 		increased lung adenocarcinoma incidence J:67456
Map2k7tm1.1Twad/Map2k7tm1.2Twad
Tg(MMTV-cre)4Mam/0
Tg(MMTV-Erbb2)1Pv/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA * FVB/N) 		increased mammary adenocarcinoma incidence J:170904
Mapk14tm1Nbr/Mapk14tm2Nbr
Polr2atm1(cre/ERT2)Bbd/Polr2a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL) 		increased lung adenocarcinoma incidence J:122397
Mcctm1.1Maija/Mcctm1.1Maija
Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL) 		increased large intestine adenocarcinoma incidence J:294342
Mcm4chaos3/Mcm4chaos3
(C3.B6-Mcm4chaos3) 		increased lung adenocarcinoma incidence J:117494
increased mammary adenocarcinoma incidence J:117494
Mdm2tm3.1Glo/Mdm2tm3.1Glo
(B6.129S6-Mdm2tm3.1Glo) 		increased mammary adenocarcinoma incidence J:164201
Mdm2tm3.1Glo/Mdm2tm3.1Glo
Trp53tm3.1Glo/Trp53+
(B6.129S-Mdm2tm3.1Glo Trp53tm3.1Glo) 		increased adenocarcinoma incidence J:164201
increased liver adenocarcinoma incidence J:164201
increased mammary adenocarcinoma incidence J:164201
Mdm2tm4.1Glo/Mdm2tm4.1Glo
Trp53tm3.1Glo/Trp53+
(B6.129S-Mdm2tm4.1Glo Trp53tm3.1Glo) 		increased adenocarcinoma incidence J:164201
increased liver adenocarcinoma incidence J:164201
Men1tm1.1Ctre/Men1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased lung adenocarcinoma incidence J:120835
Men1tm1Ctre/Men1+
(either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N)) 		increased lung adenocarcinoma incidence J:67128
Mettm4Gvw/Met+
(involves: 129 * C57BL/6J * FVB/N) 		increased mammary adenocarcinoma incidence J:151890
Mirc1tm2.1Aven/Mirc1tm2.1Aven
Tg(ARR2/Pbsn-MYC)7Key/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL/J) 		increased prostate gland adenocarcinoma incidence J:223213
Mlh1tm1Lisk/Mlh1tm1Lisk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:75745
Mlh1tm1Rak/Mlh1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased adenocarcinoma incidence J:53451
Mlh1tm1Rak/Mlh1tm1Rak
(involves: 129P2/OlaHsd) 		increased small intestine adenocarcinoma incidence J:133352
Mlh1tm1Rak/Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased intestinal adenocarcinoma incidence J:153684
Mnttm1Awb/Mnttm1.1Awb
Tg(MMTV-cre)4Mam/?
(involves: 129S6/SvEvTac * FVB/N) 		increased mammary adenocarcinoma incidence J:110115
Mnttm1Phu/Mnttm1Phu
Tg(MMTV-cre)4Mam/?
(involves: FVB) 		increased mammary adenocarcinoma incidence J:85481
Msh2tm1Mak/Msh2+
Mutyhtm1Jhmi/Mutyhtm1Jhmi
Ogg1tm1Tld/Ogg1tm1Tld
(involves: 129 * C57BL/6J) 		increased lung adenocarcinoma incidence J:89742
Msh2tm1Rak/Msh2tm2.1Rak
Tg(Vil1-cre)20Syr/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * DBA/2 * SJL) 		increased intestinal adenocarcinoma incidence J:161577
Msh2tm1Wed/Msh2tm1Wed
(involves: C57BL/6) 		increased intestinal adenocarcinoma incidence J:86278
Msh2tm1Wed/Msh2tm1Wed
(involves: 129 * C57BL/6 * SJL) 		increased intestinal adenocarcinoma incidence J:88092
Msh2tm2.1Rak/Msh2tm2.1Rak
Tg(Vil1-cre)20Syr/0
(involves: 129/Sv * C57BL/6 * FVB/N * SJL) 		increased small intestine adenocarcinoma incidence J:161577
Msh2tm2.1Rak/Msh2tm3.1Rak
Tg(Vil1-cre)20Syr/0
(involves: 129/Sv * C57BL/6 * DBA/2 * SJL) 		increased intestinal adenocarcinoma incidence J:161577
Msh3tm1Rak/Msh3tm1Rak
(involves: 129/Sv * C57BL/6J * SJL) 		increased intestinal adenocarcinoma incidence J:60604
Msh3tm1Rak/Msh3tm1Rak
Msh6tm1Rak/Msh6tm1Rak
(involves: 129/Sv * C57BL/6J * SJL) 		increased intestinal adenocarcinoma incidence J:60604
Msmbtm1Xuan/Msmbtm1Xuan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * CD-1)) 		increased prostate gland adenocarcinoma incidence J:96884
Mtv2a/Mtv2a
(DDD.GR-Mtv2a) 		increased mammary adenocarcinoma incidence J:109201
Muc2tm1Avel/Muc2tm1Avel
(involves: 129P2/OlaHsd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:75047
Nbntm1Zqw/Nbn+
(involves: 129S2/SvPas * C57BL/6) 		increased liver adenocarcinoma incidence J:86563
increased lung adenocarcinoma incidence J:86563
increased mammary adenocarcinoma incidence J:86563
Ncoa3tm1Jxu/Ncoa3+
Tg(MMTV-vHaras)SH1Led/0
(involves: 129S6/SvEvTac * C57BL/6J * CD-1) 		increased mammary adenocarcinoma incidence J:88789
Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * C57BL/6) 		increased lung adenocarcinoma incidence J:18542
Nf2tm1Gth/Nf2+
(involves: 129P2/OlaHsd * FVB/N) 		increased lung adenocarcinoma incidence J:63264
Nf2tm1Tyj/Nf2+
(either: (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) or (involves: 129S2/SvPas * C57BL/6J)) 		increased lung adenocarcinoma incidence J:47282
Nf2tm2.1Gth/Nf2+
(involves: 129P2/OlaHsd * FVB/N) 		increased lung adenocarcinoma incidence J:63264
Nf2tm2Gth/Nf2+
Tg(Mpz-cre)#Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased lung adenocarcinoma incidence J:63264
Nf2tm2Gth/Nf2tm2Gth
Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased lung adenocarcinoma incidence J:92413
Nf2tm2Gth/Nf2tm2Gth
Tg(Mpz-cre)3Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased lung adenocarcinoma incidence J:63264
Nkx3-1tm4(cre/ERT2)Mms/Nkx3-1+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:153425
Nmitm1.1Geno/Nmitm1.1Geno
Tg(KRT14-cre)1Amc/0
Tg(MMTVneu)202Mul/0
(involves: 129S/SvEv * C57BL/6 * CBA * FVB/N) 		increased mammary adenocarcinoma incidence J:261035
Nudt1tm1Tts/Nudt1tm1Tts
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		increased lung adenocarcinoma incidence J:71836
Pcbp4Gt(D136D11)Wrst/Pcbp4+
(involves: 129S2/SvPas * C57BL/6) 		increased lung adenocarcinoma incidence J:231514
Pcbp4Gt(D136D11)Wrst/Pcbp4Gt(D136D11)Wrst
(involves: 129S2/SvPas * C57BL/6) 		increased lung adenocarcinoma incidence J:231514
Pcsk2tm1Dfs/Pcsk2tm1Dfs
(B6;129-Pcsk2tm1Dfs/J) 		increased pancreatic ductal adenocarcinoma incidence J:236905
Pik3catm1.1Waph/Pik3ca+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S1/Sv * 129S4/SvJae * BALB/c * C57BL/6) 		increased adenocarcinoma incidence J:184382
Pik3catm1.1Waph/Pik3ca+
Tg(MMTV-cre)#Mam/0
(involves: 129S1/Sv * C57BL/6 * FVB) 		increased mammary adenoacanthoma incidence J:187299
Plgtm1Jld/Plgtm1Jld
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * Black Swiss * FVB/N) 		increased mammary adenocarcinoma incidence J:48285
Plk3tm1Dai/Plk3tm1Dai
(involves: 129S4/SvJae * C57BL/6) 		increased lung adenocarcinoma incidence J:136425
Pms2tm1.1Wed/Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr) 		increased adenocarcinoma incidence J:162378
Pold1tm1.1Bdp/Pold1tm1.1Bdp
(B6.129-Pold1tm1.1Bdp) 		increased intestinal adenocarcinoma incidence J:153684
Pold1tm1Bdp/Pold1tm1Bdp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lung adenocarcinoma incidence J:100685
Poletm1.1Bdp/Poletm1.1Bdp
(B6.129-Poletm1.1Bdp) 		increased colon adenocarcinoma incidence J:153684
increased intestinal adenocarcinoma incidence J:153684
increased small intestine adenocarcinoma incidence J:153684
Ppardtm1Jps/Ppardtm1Jps
(involves: 129/Sv * C57BL/6N) 		increased intestinal adenocarcinoma incidence J:90217
Ppp2r1atm1.2Wltr/Ppp2r1atm2.1Wltr
(FVB.129-Ppp2r1atm1.2Wltr/Ppp2r1atm2.1Wltr) 		increased lung adenocarcinoma incidence J:175748
Prdm2tm1Shg/Prdm2+
(involves: 129S2/SvPas * C57BL/6) 		increased lung adenocarcinoma incidence J:71406
Prdm2tm1Shg/Prdm2tm1Shg
(involves: 129S2/SvPas * C57BL/6) 		increased lung adenocarcinoma incidence J:71406
Prdx1tm1Rave/Prdx1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased lung adenocarcinoma incidence J:84677
increased mammary adenocarcinoma incidence J:84677
Prdx1tm1Rave/Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6) 		increased lung adenocarcinoma incidence J:84677
increased mammary adenocarcinoma incidence J:84677
Prf1tm1Sdz/Prf1tm1Sdz
(C.B6-Prf1tm1Sdz) 		increased lung adenocarcinoma incidence J:77491
Pscatm1Witt/Psca+
Tg(TRAMP)8247Ng/0
(involves: 129/Sv * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:133908
Pscatm1Witt/Pscatm1Witt
Tg(TRAMP)8247Ng/0
(involves: 129/Sv * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:133908
Ptentm1.1Hwu/Pten+
(involves: 129S4/SvJae * BALB/c) 		increased mammary adenocarcinoma incidence J:110567
Ptentm1.1Mwst/Ptentm1.1Mwst
Tg(MMTVneu)202Mul/0
Tg(S100a4-cre)1Gle/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:153747
Ptentm1.2Mwst/Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased mammary adenoacanthoma incidence J:158751
Ptentm1Hwu/Pten+
Tg(ARR2/Pbsn-FGF8)3Prb/0
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:106650
Ptentm1Hwu/Pten+
Tg(KRT14-cre)#Smr/0
(involves: 129S4/SvJae * C57BL/6J * SJL/J) 		increased mammary adenocarcinoma incidence J:138927
Ptentm1Hwu/Pten+
Tmprss2tm2.1(ETV1)Sho/Tmprss2tm2.1(ETV1)Sho
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:212219
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae) 		increased prostate gland adenocarcinoma incidence J:144810
Ptentm1Hwu/Ptentm1Hwu
Cop1tm2.1Vmd/Cop1tm2.1Vmd
Tg(Pbsn-cre)4Prb/0
(B6N.CgCop1tm2.1Vmd Ptentm1Hwu Tg(Pbsn-cre)4Prb) 		increased prostate gland adenocarcinoma incidence J:172653
Ptentm1Hwu/Ptentm1Hwu
Ptpn1tm1Bpk/Ptpn1tm1Bpk
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:231906
Ptentm1Hwu/Ptentm1Hwu
Tg(CAG-MYC,-GFP*)#Rugg/0
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA/2) 		increased prostate gland adenocarcinoma incidence J:261540
Ptentm1Hwu/Ptentm1Hwu
Tg(Fabp1-cre)1Jig/0
(involves: 129S4/SvJae * FVB/N) 		increased colon adenocarcinoma incidence J:106662
Ptentm1Hwu/Ptentm1Hwu
Tg(KRT14-cre)#Smr/0
(involves: 129S4/SvJae * C57BL/6J * SJL/J) 		increased mammary adenocarcinoma incidence J:138927
Ptentm1Hwu/Ptentm1Hwu
Tg(MMTV-cre)#Tfln/0
(involves: 129S4/SvJae) 		increased mammary adenocarcinoma incidence J:78415
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129 * 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:142106
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:268934, J:184935, J:212219
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:93902, J:124208
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)20Fwan/?
(involves: 129S4/SvJae * C57BL/6 * FVB/NCrl) 		increased prostate gland adenocarcinoma incidence J:238768
Ptentm1Hwu/Ptentm1Hwu
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		increased pancreatic ductal adenocarcinoma incidence J:102226
Ptentm1Hwu/Ptentm1Hwu
Tg(Pdx1-cre)89.1Dam/0
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 * CBA) 		increased pancreatic acinar cell carcinoma incidence J:102226
increased pancreatic ductal adenocarcinoma incidence J:102226
Ptentm1Hwu/Ptentm1Hwu
Tg(Pgc-cre,-secNluc)#Hcz/0
(involves: 129S4/SvJae) 		increased mammary adenocarcinoma incidence J:338079
Ptentm1Mak/Pten+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased mammary adenocarcinoma incidence J:63478
Ptentm1Mro/Pten+
Tg(KLK3-cre)D4Trp/0
(involves: 129P2/OlaHsd * FVB) 		increased prostate gland adenocarcinoma incidence J:99524
Ptentm1Ppp/Pten+
Tg(Pbsn-TAg)15Tvd/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:103408
Ptentm1Rdp/Ptentm1Rdp
Smad4tm1Rdp/Smad4tm1Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129 * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
Ptentm1Rdp/Ptentm1Rdp
Terttm1Rdp/Tert+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
Ptentm1Rdp/Ptentm1Rdp
Terttm3Rdp/Terttm3Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
Ptentm1Rdp/Ptentm1Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
Ptentm1Rps/Pten+
Tg(Wnt1)1Hev/0
(involves: 129S1/Sv * C57BL/6 * FVB/N * SJL) 		increased adenocarcinoma incidence J:67497
increased mammary adenocarcinoma incidence J:67497
increased salivary adenocarcinoma incidence J:67497
Ptentm2.1Gle/Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased mammary adenoacanthoma incidence J:158751
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:163589, J:100683
Ptentm2Mak/Ptentm2Mak
Tg(KLK3-cre)13Saa/0
(involves: 129P2/OlaHsd * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:214242
Ptentm2Mak/Ptentm2Mak
Tg(MMTV-cre)#Tfln/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:224955
Ptentm2Mak/Ptentm2Mak
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-cre)1Jaw/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased lung adenocarcinoma incidence J:127405
Ptentm2Mak/Ptentm2Mak
Tg(Wap-cre)11738Mam/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL) 		increased mammary adenocarcinoma incidence J:224955
Ptentm2Mak/Ptentm2Mak
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)#Tfln/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:224955
Ptentm2Mak/Ptentm2Mak
Trp53tm1Brn/Trp53tm1Brn
Tg(Wap-cre)11738Mam/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL) 		increased mammary adenocarcinoma incidence J:224955
Rab25tm1Jrgo/Rab25tm1Jrgo
Smad3tm1Par/Smad3+
(129-Rab25tm1Jrgo Smad3tm1Par) 		increased colon adenocarcinoma incidence J:158733
Rag2tm1Fwa/Rag2tm1Fwa
Stat1tm1Rds/Stat1tm1Rds
(involves: 129S/SvEv * 129S6/SvEvTac) 		increased mammary adenocarcinoma incidence J:216040
Rasal2Gt(463C12)Cmhd/Rasal2Gt(463C12)Cmhd
Tg(MMTVneu)202Mul/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl * FVB/N) 		increased mammary adenocarcinoma incidence J:202603
Rassf1tm1.2Brd/Rassf1tm1.2Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased intestinal adenocarcinoma incidence J:101369
Rassf5tm1Kina/Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina) 		increased lung adenocarcinoma incidence J:168749
Rb1tm1.1Jyjw/Rb1tm1.1Jyjw
Trp53tm1Tyj/Trp53tm1Tyj
(129S6.129-Trp53tm1Tyj Rb1tm1.1Jyjw) 		increased intestinal adenocarcinoma incidence J:102483
Rb1tm2Brn/Rb1+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd) 		increased lung adenocarcinoma incidence J:86077
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd) 		increased lung adenocarcinoma incidence J:86077, J:157319
Rhoctm1Mak/Rhoctm1Mak
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:100482
Rint1tm1Whl/Rint1+
(Not Specified) 		increased lung adenocarcinoma incidence J:122805
increased mammary adenocarcinoma incidence J:122805
Rnf8Gt(AS0574)Wtsi/Rnf8Gt(AS0574)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased mammary adenocarcinoma incidence J:161240
Rnf8Gt(RRR260)Byg/Rnf8Gt(RRR260)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased mammary adenocarcinoma incidence J:161240
Rnf20Gt(RRJ249)Byg/Rnf20+
(involves: 129P2/OlaHsd) 		increased colon adenocarcinoma incidence J:268221
increased large intestine adenocarcinoma incidence J:268221
Robo1tm1Phr/Robo1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lung adenocarcinoma incidence J:93666
S100a4tm1Amba/S100a4tm1Amba
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		increased mammary adenocarcinoma incidence J:89563
Scribtm1.2Phum/Scrib+
(involves: FVB/N) 		increased lung adenocarcinoma incidence J:178461
Sluc10B10.O20/Dem/Sluc10B10.O20/Dem
Sluc25O20/A/Sluc25O20/A
(involves: B10.O20/Dem * O20/A) 		increased lung adenocarcinoma incidence J:71973
Sluc10O20/A/Sluc10O20/A
Sluc25O20/A/Sluc25O20/A
(involves: B10.O20/Dem * O20/A) 		increased lung adenocarcinoma incidence J:71973
Sluc18B10.O20/Dem/Sluc18B10.O20/Dem
Sluc26B10.O20/Dem/Sluc26B10.O20/Dem
(involves: B10.O20/Dem * O20/A) 		increased lung adenocarcinoma incidence J:71973
Sluc25O20/A/Sluc25O20/A
Sluc5B10.O20/Dem/Sluc5B10.O20/Dem
(involves: B10.O20/Dem * O20/A) 		increased lung adenocarcinoma incidence J:71973
Sluc25O20/A/Sluc25O20/A
Sluc9B10.O20/Dem/Sluc9O20/A
(involves: B10.O20/Dem * O20/A) 		increased lung adenocarcinoma incidence J:71973
Sluc25O20/A/Sluc25O20/A
Sluc9O20/A/Sluc9O20/A
(involves: B10.O20/Dem * O20/A) 		increased lung adenocarcinoma incidence J:71973
Smad3tm1Cxd/Smad3tm1Cxd
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss)) 		increased intestinal adenocarcinoma incidence J:53510
Smad3tm1Par/Smad3tm1Par
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		increased intestinal adenocarcinoma incidence J:49839
Smad3tm1Par/Smad3tm1Par
(129-Smad3tm1Par/J) 		increased intestinal adenocarcinoma incidence J:106572
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)7Mul/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * FVB/N) 		increased mammary adenocarcinoma incidence J:212549
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased intestinal adenocarcinoma incidence J:212549
Smarca4tm1Mag/Smarca4+
(involves: 129S/Sv * C57BL/6J * CD-1) 		increased mammary adenocarcinoma incidence J:132091
Smg1Gt(AG0297)Wtsi/Smg1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lung adenocarcinoma incidence J:193626
Smurf2Gt(RRA098)Byg/Smurf2Gt(RRA098)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased small intestine adenocarcinoma incidence J:189320
Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac) 		increased lung adenocarcinoma incidence J:166879
Srpxtm1Hzi/Srpxtm1Hzi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lung adenocarcinoma incidence J:119999
Ssbp2tm1Lana/Ssbp2tm1Lana
(involves: 129S/SvEv * C57BL/6) 		increased jejunum adenocarcinoma incidence J:162035
Ssic1C57BL/10J/Ssic1C57BL/10J
(involves: C57BL/10 * O20/A) 		increased small intestine adenocarcinoma incidence J:26873
Stat1tm1Dlv/Stat1tm1Dlv
(B6.129S-Stat1tm1Dlv) 		increased mammary adenocarcinoma incidence J:216040
Stat1tm1Rds/Stat1tm1Rds
(129S6/SvEv-Stat1tm1Rds/Tac) 		increased mammary adenocarcinoma incidence J:216040
Stat3tm4Vpo/Stat3tm4Vpo
Tg(MMTV-Erbb2)1Pv/0
(involves: 129P2/OlaHsd * BALB/cAn * C57BL/6 * CD-1 * DBA) 		increased mammary adenocarcinoma incidence J:157976
T(9;17)138Ca/T(9;17)138Ca
(Not Specified) 		increased adenocarcinoma incidence J:189952
Tbx21tm1Glm/Tbx21tm1Glm
Tg(TRAMP)8247Ng/0
(involves: 129S6/SvEvTac * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:88093
Tcf7tm1Cle/Tcf7tm1Cle
(involves: 129P2/OlaHsd) 		increased mammary adenoacanthoma incidence J:57721
Tg(ACTB-Eif4e)#Ppp/?
(Not Specified) 		increased lung adenocarcinoma incidence J:89878
Tg(ACTB-KRAS*G12V,-luc)#Lche/0
(involves: C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:199528
Tg(ARR2/Pbsn-MYC)7Key/?
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:223213, J:85480
Tg(C3-1-TAg)cJeg/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:52786, J:46513
increased prostate gland adenocarcinoma incidence J:52786, J:46513, J:72324
Tg(CAG-Bgeo,-Tle1,-ALPP)1Lbe/0
Tg(CAG-cre)1Nagy/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased lung adenocarcinoma incidence J:106684
Tg(CAG-Bgeo,-tTA,-EGFP)2A11Kuw/0
Tg(Pdx1-cre)6Tuv/0
Tg(tetO-MYC)36Bop/0
(involves: 129P2/OlaHsd * FVB/N) 		increased pancreatic ductal adenocarcinoma incidence J:197052
Tg(CAG-Has2)99Nita/0
Tg(MMTV-cre)4Mam/0
Tg(MMTVneu)202Mul/0
(FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTV-cre)4Mam Tg(MMTVneu)202Mul) 		increased mammary adenocarcinoma incidence J:130531, J:164205
Tg(CAG-Has2)99Nita/0
Tg(MMTVneu)202Mul/0
(FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTVneu)202Mul) 		increased mammary adenocarcinoma incidence J:130531
Tg(CAG-Tle1,-ALPP)1Lbe/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased lung adenocarcinoma incidence J:106684
Tg(CEACAM5-Tag)L5496Wzm/0
(involves: C57BL/6 * CBA) 		increased gastric adenocarcinoma incidence J:62581
Tg(Cela1-luc,Cela1-TAg)#Nzh/0
(involves: FVB/N) 		increased pancreatic acinar cell carcinoma incidence J:207960
Tg(ED-L2-IL1RN/IL1B)#Tcw/?
(B6.Cg-Tg(ED-L2-IL1RN/IL1B)#Tcw) 		increased adenocarcinoma incidence J:180282
Tg(Ela1-Myc)158Bri/0
(involves: C57BL/6 * SJL) 		increased pancreatic acinar cell carcinoma incidence J:76992
Tg(Ela1-Myc)159Bri/0
(involves: C57BL/6 * SJL) 		increased pancreatic acinar cell carcinoma incidence J:76992
Tg(Ela1-Myc)160Bri/0
(involves: C57BL/6 * SJL) 		increased pancreatic acinar cell carcinoma incidence J:76992
Tg(Ela1-TAg)18Bri/0
(involves: C57BL/6 * SJL) 		increased pancreatic acinar cell carcinoma incidence J:76995
Tg(Ela1-TAg)19Bri/0
(involves: C57BL/6 * SJL) 		increased pancreatic acinar cell carcinoma incidence J:76995
Tg(Ela1-TAg*)79Mjt/0
(involves: C57BL/6 * DBA/2) 		increased pancreatic acinar cell carcinoma incidence J:78026
Tg(Ela1-TAg*)79Mjt/0
Tg(MUC1)79.24Gend/0
(involves: C57BL/6 * DBA/2) 		increased pancreatic acinar cell carcinoma incidence J:64570
Tg(Ela1-TAg*)289Mjt/0
(involves: C57BL/6 * DBA/2) 		increased pancreatic acinar cell carcinoma incidence J:78026
Tg(Ela1-Tgfa)150Bri/0
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL) 		increased pancreatic ductal adenocarcinoma incidence J:67389
Tg(Erbb2-Erbb2*V664E)#Led/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:62441
Tg(Gcg-TAg)25Ddr/?
(involves: CD-1) 		increased large intestine adenocarcinoma incidence J:91490, J:101537
Tg(H-2K1-Lrp5/Fkbp1a,-luc*)#Dmps/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:206727, J:184212
Tg(H-2K1-Lrp5/Fkbp1a,-luc*)#Dmps/0
Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:206727
Tg(HRAS)2Jic/?
(involves: BALB/c * C57BL/6) 		increased adenocarcinoma incidence J:64968
increased lung adenocarcinoma incidence J:64968
Tg(HRAS)7Mok/?
(involves: C57BL/6) 		increased adenocarcinoma incidence J:64968
increased lung adenocarcinoma incidence J:64968
Tg(KRT5-Akt1*)Jmpa/0
(involves: C57BL/6 * DBA/2 * DBA/2J * FVB/N) 		increased adenocarcinoma incidence J:144831
Tg(Krt19-Ptgs2,Krt19-Ptges)8Tko/0
Tg(Krt19-Wnt1)2Maos/0
(involves: C3H * C57BL/6) 		increased gastric adenocarcinoma incidence J:116782
Tg(Ly6a-BCR/ABL1)IS1AIsg/0
(involves: C57BL/6J * CBA) 		increased lung adenocarcinoma incidence J:144382
Tg(Ly6a-BCR/ABL1)IS1BIsg/0
(involves: C57BL/6J * CBA) 		increased lung adenocarcinoma incidence J:144382
Tg(Mdm2)1Snj/0
(involves: 129S7/SvEvBrd * C57BL/6) 		increased adenocarcinoma incidence J:51661
Tg(MMTV-AURKA)#Cxd/?
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:145680
Tg(MMTV-AURKA)#Cxd/?
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * FVB/N) 		increased mammary adenocarcinoma incidence J:145680
Tg(MMTV-CCND1)1Esmp/0
(Not Specified) 		increased mammary adenoacanthoma incidence J:70571
increased mammary adenocarcinoma incidence J:70571
Tg(MMTV-CCND1)1Esmp/0
Tg(MMTV-Cdc37)1Stp/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased mammary adenocarcinoma incidence J:62465
Tg(MMTV-Cdc37)1Stp/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased mammary adenoacanthoma incidence J:62465
increased mammary adenocarcinoma incidence J:62465
Tg(MMTV-Cdc37)1Stp/0
Tg(MMTV-Myc)141-3Led/0
(involves: C57BL/6 * CD-1 * DBA/2 * FVB/N) 		increased mammary adenocarcinoma incidence J:62465
increased salivary adenocarcinoma incidence J:62465
Tg(MMTV-Cdc37)2Stp/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased mammary adenoacanthoma incidence J:62465
Tg(MMTV-ENPP2)20Gbm/0
(FVB/N-Tg(MMTV-ENPP2)20Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-ENPP2)21Gbm/0
(FVB/N-Tg(MMTV-ENPP2)21Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-ENPP2)#Gbm/0
(FVB/N-Tg(MMTV-ENPP2)#Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-Erbb2)1Pv/0
(involves: BALB/c * C57BL/6 * CD-1 * DBA) 		increased mammary adenocarcinoma incidence J:234420
Tg(MMTV-ERBB2)5Erick/?
(FVB/N-Tg(MMTV-ERBB2)5Erick) 		increased mammary adenocarcinoma incidence J:90202
Tg(MMTV-Erbb2)9Pjo/0
(involves: BALB/c * C3H * C57BL/6) 		increased mammary adenocarcinoma incidence J:72129
Tg(MMTV-Erbb2)10Pjo/0
(involves: BALB/c * C3H * C57BL/6) 		increased mammary adenocarcinoma incidence J:72129
Tg(MMTV-Erbb2)12Pjo/0
(involves: BALB/c * C3H * C57BL/6) 		increased mammary adenocarcinoma incidence J:72129
Tg(MMTV-Erbb2)17Pjo/0
(involves: BALB/c * C3H * C57BL/6) 		increased mammary adenocarcinoma incidence J:72129
Tg(MMTV-Erbb2)NA1Mul/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:48632
Tg(MMTV-Erbb2)NF1Mul/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:48632
Tg(MMTV-Erbb2)NF1Mul/0
(involves: CD-1 * FVB/N) 		increased mammary adenocarcinoma incidence J:48632
Tg(MMTV-Erbb2)NF1Mul/0
(FVB/N-Tg(MMTV-Erbb2)NF1Mul) 		increased mammary adenocarcinoma incidence J:48632
Tg(MMTV-Erbb2)NK1Mul/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:48632
Tg(MMTV-Erbb2)NK1Mul/Tg(MMTV-Erbb2)NK1Mul
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
Tg(MMTV-ERBB2*,-luc)6157Aami/0
(FVB-Tg(MMTV-ERBB2*,-luc)6157Aami) 		increased mammary adenocarcinoma incidence J:172352
Tg(MMTV-ERBB3)1Slg/0
(involves: FVB) 		increased lung adenocarcinoma incidence J:80974
Tg(MMTV-ERBB3)1Slg/0
Tg(MMTVneu)202Mul/0
(involves: FVB) 		increased lung adenocarcinoma incidence J:80974
Tg(MMTV-Espl1)1Pati/0
(involves: C57BL/6) 		increased mammary adenocarcinoma incidence J:216267
Tg(MMTV-KRAS*G12V)3025Mrl/0
(involves: C57BL/6 * FVB * SJL) 		increased mammary adenocarcinoma incidence J:77272
Tg(MMTV-LPAR1)2Gbm/Tg(MMTV-LPAR1)2Gbm
(FVB/N-Tg(MMTV-LPAR1)2Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR1)7Gbm/Tg(MMTV-LPAR1)7Gbm
(FVB/N-Tg(MMTV-LPAR1)7Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR1)27Gbm/Tg(MMTV-LPAR1)27Gbm
(FVB/N-Tg(MMTV-LPAR1)27Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR1)#Gbm/Tg(MMTV-LPAR1)#Gbm
(FVB/N-Tg(MMTV-LPAR1)#Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR2)3Gbm/Tg(MMTV-LPAR2)3Gbm
(FVB/N-Tg(MMTV-LPAR2)3Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR2)6Gbm/Tg(MMTV-LPAR2)6Gbm
(FVB/N-Tg(MMTV-LPAR2)6Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR2)#Gbm/Tg(MMTV-LPAR2)#Gbm
(FVB/N-Tg(MMTV-LPAR2)#Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR3)3Gbm/Tg(MMTV-LPAR3)3Gbm
(FVB/N-Tg(MMTV-LPAR3)3Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR3)22Gbm/Tg(MMTV-LPAR3)22Gbm
(FVB/N-Tg(MMTV-LPAR3)22Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-LPAR3)#Gbm/Tg(MMTV-LPAR3)#Gbm
(FVB/N-Tg(MMTV-LPAR3)#Gbm) 		increased mammary adenocarcinoma incidence J:149661
Tg(MMTV-Myc)WT13Jrn/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:153233
Tg(MMTV-Myc)WT21Jrn/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:153233
Tg(MMTV-Myc*T58A)TA14Jrn/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:153233
Tg(MMTV-Myc*T58A)TA41Jrn/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:153233
Tg(MMTV-NCOA3)#Mybr/0
(FVB/N-Tg(MMTV-NCOA3)#Mybr) 		increased lung adenocarcinoma incidence J:93548
increased mammary adenocarcinoma incidence J:93548
Tg(MMTV-neu/OT-I/OT-II)CBnel/?
Tg(Trp53R172H)8512Jmr/?
(involves: C57BL/6 * FVB) 		increased mammary adenocarcinoma incidence J:122846
Tg(MMTV-Notch4)3Rnc/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:11644
increased salivary adenocarcinoma incidence J:11644
Tg(MMTV-PTGS2)#Thla/0
(involves: CD-1) 		increased adenocarcinoma incidence J:68565
increased mammary adenocarcinoma incidence J:68565
Tg(MMTV-PyVT)634Mul/0
(FVB/N-Tg(MMTV-PyVT)634Mul/Nci) 		increased mammary adenocarcinoma incidence J:46460, J:51424, J:87544, J:48285
Tg(MMTV-PyVT)634Mul/0
(multiple strains) 		increased mammary adenocarcinoma incidence J:48854
Tg(MMTV-PyVT)634Mul/0
(involves: 129 * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:117336
Tg(MMTV-PyVT)634Mul/0
(B6.FVB-Tg(MMTV-PyVT)634Mul) 		increased mammary adenocarcinoma incidence J:350496
Tg(MMTV-PyVT)#Mul/0
(B6.FVB-Tg(MMTV-PyVT)#Mul) 		increased mammary adenocarcinoma incidence J:147923
Tg(MMTV-PyVT*Y250F)250-2Mul/?
(FVB/N-Tg(MMTV-PyVT*Y250F)250-2Mul) 		increased mammary adenocarcinoma incidence J:56327
Tg(MMTV-PyVT*Y315F*Y322F)Db-1Mul/?
(FVB/N-Tg(MMTV-PyVT*Y315F*Y322F)Db-1Mul) 		increased mammary adenocarcinoma incidence J:56327
Tg(MMTV-rtTA)1Lach/0
Tg(TetO-Erbb2)1Lach/0
(involves: FVB) 		increased mammary adenocarcinoma incidence J:81083
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-ERBB2)#Jjz/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:231766
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-IGF1R)1Ramo/0
(involves: FVB) 		increased mammary adenocarcinoma incidence J:121069
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-MYC)1Lach/0
(involves: FVB) 		increased mammary adenocarcinoma incidence J:67498
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-PIK3CA*H1047R,-luc)2239Jjz/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:175839
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-PyVT,-cre)1Mul/0
(FVB/N-Tg(MMTV-rtTA)1Lach Tg(tetO-PyVT,-cre)#Mul) 		increased mammary adenocarcinoma incidence J:231983
Tg(MMTV-TGFBR2)7Hlm/?
Tg(MMTVTGFA)29Rjc/?
(involves: C57BL/6 * DBA) 		increased mammary adenocarcinoma incidence J:85799
Tg(MMTV-TGFBR2)7Hlm/Tg(MMTV-TGFBR2)7Hlm
(involves: C57BL/6 * DBA) 		increased mammary adenocarcinoma incidence J:85799
Tg(MMTV-vHaras)SH1Led/Tg(MMTV-vHaras)SH1Led
(involves: 129X1/SvJ * C57BL/6J * CD-1 * FVB) 		increased mammary adenocarcinoma incidence J:86074
Tg(MMTVneu)202Mul/0
(FVB/N-Tg(MMTVneu)202Mul) 		increased mammary adenocarcinoma incidence J:56332
Tg(MMTVneu)202Mul/0
Tg(Trp53R172H)8512Jmr/0
(C.FVB-Tg(MMTVneu)202Mul Tg(Trp53R172H)8512Jmr) 		increased mammary adenocarcinoma incidence J:115041
Tg(MMTVTGFA)29Rjc/0
(involves: C57BL/6 * DBA/2) 		increased mammary adenocarcinoma incidence J:72085, J:72080, J:28453, J:71696
Tg(MMTVTGFA)254Rjc/0
(involves: C57BL/6 * DBA/2) 		increased mammary adenocarcinoma incidence J:72085
Tg(Msmb-TAg)183-2Xuan/0
(involves: C57BL/6 * CBA) 		increased prostate gland adenocarcinoma incidence J:80313
Tg(Mt1-Tgfa)147Bri/0
(involves: C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:56318
Tg(MtTGFA)100Lmb/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:72083
Tg(Pbsn-Ar*E231G)7353Ng/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:96117
Tg(Pbsn-ERG*)1Vv/0
(involves: 129S1/SvImJ * C57BL/6J * CBA) 		increased prostate gland adenocarcinoma incidence J:222916
Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp/0
(FVB-Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp) 		increased prostate gland adenocarcinoma incidence J:130340
Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp/0
Tg(Pbsn-Lrp5/Fkbp1a,-luc*)#Dmps/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:206727
Tg(Pbsn-Hpn,-GFP)DVv/0
Tg(Pbsn-Tag)12T7fRjm/0
(involves: C57BL/6J * CBA * CD-1) 		increased prostate gland adenocarcinoma incidence J:92562
Tg(Pbsn-MYC)6Key/?
(involves: FVB) 		increased prostate gland adenocarcinoma incidence J:85480
Tg(Pbsn-MYC)#Tt/?
(involves: C57BL/6J) 		increased prostate gland adenocarcinoma incidence J:205395
Tg(Pbsn-Tag)12T7fRjm/0
(involves: CD-1) 		increased prostate gland adenocarcinoma incidence J:48623
Tg(Pbsn-Tag)12T10Rjm/0
(involves: CD-1) 		increased prostate gland adenocarcinoma incidence J:68483, J:48623
Tg(Pbsn-TAg)15Tvd/0
(involves: C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:103408
Tg(Pklr-SV40)1Ak/0
(involves: C57BL/6 * DBA) 		increased adenocarcinoma incidence J:185488
Tg(RasE)290Biat/0
(involves: C57BL/6 * DBA/2) 		increased lung adenocarcinoma incidence J:226601
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*delta19)11Hev/0
(involves: C57BL/6 * CBA) 		increased lung adenocarcinoma incidence J:109092
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*L858R)56Hev/0
(involves: C57BL/6 * CBA) 		increased lung adenocarcinoma incidence J:109092
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*L858R)57Hev/0
(involves: C57BL/6 * CBA) 		increased lung adenocarcinoma incidence J:109092
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*L858R)#Hev/0
(involves: 129 * C57BL/6 * CBA) 		increased lung adenocarcinoma incidence J:128700, J:213447
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*T790M)8Paow/0
(involves: 129 * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:128700
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*T790M*L858R)19Kkw/0
(involves: 129 * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:122849
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*T790M*L858R)51Paow/0
(involves: 129 * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:128700
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-Kras2)12Hev/0
(involves: 129 * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:73468
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-Kras2)12Hev/0
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:73468
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-MYC)36Bop/0
(involves: 129 * C57BL/6) 		increased lung adenocarcinoma incidence J:169920
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-PIK3CA*H1047R)13Lca/0
(involves: 129 * C57BL/6 * FVB/N) 		increased lung adenocarcinoma incidence J:142254
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO/CMV-KRAS*G12C)9.1Msmi/0
(involves: FVB/N) 		increased lung adenocarcinoma incidence J:102839
Tg(SFTPC-CCNE1)1Edm/?
(involves: FVB/N) 		increased lung adenocarcinoma incidence J:122698
Tg(SFTPC-CCNE1*T62A*T380A)3Edm/?
(involves: FVB/N) 		increased lung adenocarcinoma incidence J:122698
Tg(SFTPC-CCNE1*T62A*T380A)4Edm/?
(involves: FVB/N) 		increased lung adenocarcinoma incidence J:122698
Tg(SFTPC-CD74/ROS1)125Tno/0
(C57BL/6J-Tg(SFTPC-CD74/ROS1)125Tno) 		increased lung adenocarcinoma incidence J:231770
Tg(SFTPC-EGFR*L858R)4-3Kkiu/0
(involves: C57BL/6Cr) 		increased lung adenocarcinoma incidence J:152157
Tg(SFTPC-EML4/ALK)502-4Hima/0
(involves: C57BL/6J) 		increased lung adenocarcinoma incidence J:142679
Tg(SFTPC-env)1Yhch/0
(FVB/N-Tg(SFTPC-env)1Yhch) 		increased lung adenocarcinoma incidence J:153538, J:247986
Tg(SFTPC-EZR/ROS1)AShiba/0
(C57BL/6-Tg(SFTPC-EZR/ROS1)AShiba) 		increased lung adenocarcinoma incidence J:199415
Tg(SFTPC-KIF5B/RET)1Tkoh/0
(involves: C57BL/6J) 		increased lung adenocarcinoma incidence J:215989
Tg(SFTPC-MST1R)71Mhw/0
(involves: C3H * C57BL/6) 		increased lung adenocarcinoma incidence J:79080
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-Fgf9,-EGFP)#Dor/0
(involves: FVB) 		increased lung adenocarcinoma incidence J:204282
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-MYC)36Bop/0
(Not Specified) 		increased lung adenocarcinoma incidence J:169920
Tg(SFTPC-SDC4/ROS1)141Tno/0
(C57BL/6J-Tg(SFTPC-SDC4/ROS1)141Tno) 		increased lung adenocarcinoma incidence J:231770
Tg(Smgb-TAg)8Mir/Tg(Smgb-TAg)8Mir
(involves: BALB/cJ * C57BL/6J) 		increased salivary adenocarcinoma incidence J:66189
Tg(TRAMP)8247Ng/0
(involves: C57BL/6) 		increased prostate gland adenocarcinoma incidence J:217920, J:65303
Tg(TRAMP)8247Ng/0
(involves: C3H * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:125633
Tg(TRAMP)8247Ng/0
(involves: 129/Sv * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:133908
Tg(TRAMP)8247Ng/0
Usp11tm1Tac/Y
(involves: 129 * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:270214
Tg(Trp53A135V)L3Ber/0
(involves: C57BL/6 * CD-1) 		increased lung adenocarcinoma incidence J:73757
Tg(Trp53R172H)8512Jmr/0
(involves: FVB) 		increased mammary adenocarcinoma incidence J:46426
Tg(Utg-TAg)7593Fjd/?
(involves: FVB) 		increased lung adenocarcinoma incidence J:70785
Tg(Utg-TAg)7736Fjd/?
(involves: FVB) 		increased lung adenocarcinoma incidence J:70785
Tg(Utg-TAg)#Fjd/?
(involves: FVB) 		increased lung adenocarcinoma incidence J:70785
Tg(Vil1-Lin28b,-tdTomato)HiAru/0
(involves: C57BL/6J * SJL) 		increased small intestine adenocarcinoma incidence J:202923
Tg(Vil1-Lin28b,-tdTomato)MedAru/0
(involves: C57BL/6J * SJL) 		increased small intestine adenocarcinoma incidence J:202923
Tg(Wap-Hgf)402Mig/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:86776
Tg(Wap-Hgf)402Mig/0
(FVB/N-Tg(Wap-Hgf)402Mig) 		increased mammary adenocarcinoma incidence J:206839
X/Tg(Wap-HRAS)69Lln
(involves: C57BL/6 * SJL) 		increased adenocarcinoma incidence J:72262
increased salivary adenocarcinoma incidence J:46458
Tg(Wap-tAg)1Gmn/?
(involves: NMRI) 		increased mammary adenocarcinoma incidence J:69711
Tg(Wap-Tsg101)4389Kuw/0
(FVB/N-Tg(Wap-Tsg101)4389Kuw) 		increased mammary adenocarcinoma incidence J:121475
Tg(WapMyc)212Bri/0
(involves: C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:56318
Tg(WapNotch4)10Rnc/0
(involves: FVB/N) 		increased mammary adenocarcinoma incidence J:33193
Tg(WapTAg)1Knw/0
(C57BL/6J-Tg(WapTAg)1Knw/J) 		increased mammary adenocarcinoma incidence J:53175
Tg(WapTAg)3Knw/0
(C57BL/6J-Tg(WapTAg)3Knw) 		increased adenocarcinoma incidence J:53175
increased mammary adenocarcinoma incidence J:53175
Tg(WapTgfa)215Bri/0
(involves: C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:56318
Tg(Wnt1)1Hev/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:54215
Tg(Wnt1)1Hev/0
(involves: C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:61009
Tgfb1tm1Rif/Tgfb1tm1Rif
(either: (involves: 129) or (involves: 129S/SvEv * C57BL/6)) 		increased anal adenocarcinoma incidence J:142353
increased colon adenocarcinoma incidence J:142353
increased gastric adenocarcinoma incidence J:142353
increased large intestine adenocarcinoma incidence J:142353
increased rectum adenocarcinoma incidence J:142353
Tgfbitm1Zhao/Tgfbitm1Zhao
(involves: 129 * C57BL/6J) 		increased lung adenocarcinoma incidence J:143036
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tg(Col1a2-cre/ERT,-ALPP)7Cpd/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:204736
Thbs1tm1Hyn/Thbs1tm1Hyn
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased adenocarcinoma incidence J:72391
increased liver adenocarcinoma incidence J:72391
increased lung adenocarcinoma incidence J:72391
increased mammary adenocarcinoma incidence J:72391
Thbs1tm1Hyn/Thbs1tm1Hyn
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased adenocarcinoma incidence J:72391
increased small intestine adenocarcinoma incidence J:72391
Tle5tm1.1Mmt/Tle5tm1.1Mmt
Apctm1Mmt/Apc+
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S2/SvPas * C57BL/6 * DBA * SJL) 		increased colon adenocarcinoma incidence J:168065
increased small intestine adenocarcinoma incidence J:168065
Tnk1tm1Sksuf/Tnk1+
(involves: 129X1/SvJ * C57BL/6) 		increased intestinal adenocarcinoma incidence J:140639
Tnk1tm1Sksuf/Tnk1tm1Sksuf
(involves: 129X1/SvJ * C57BL/6) 		increased lung adenocarcinoma incidence J:140639
Tpx2Gt(D028B03)Wrst/Tpx2+
(involves: 129S2/SvPas * C57BL/6J) 		increased lung adenocarcinoma incidence J:184948
Trim62tm1Akil/Trim62+
(involves: 129S/SvEv * C57BL/6) 		increased adenocarcinoma incidence J:204336
increased liver adenocarcinoma incidence J:204336
increased lung adenocarcinoma incidence J:204336
increased mammary adenocarcinoma incidence J:204336
Trim62tm1Akil/Trim62tm1Akil
(involves: 129S/SvEv * C57BL/6) 		increased adenocarcinoma incidence J:204336
increased liver adenocarcinoma incidence J:204336
increased lung adenocarcinoma incidence J:204336
increased mammary adenocarcinoma incidence J:204336
Trp53tm1Brn/Trp53+
Tg(MMTV-cre)#Tfln/0
(involves: 129P2/OlaHsd) 		increased mammary adenocarcinoma incidence J:170898
Trp53tm1Brn/Trp53tm1.1Brn
(involves: 129P2/OlaHsd) 		increased lung adenocarcinoma incidence J:86077, J:157319
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd) 		increased lung adenocarcinoma incidence J:86077, J:157319
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:116152
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)#Tfln/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased mammary adenocarcinoma incidence J:224955
Trp53tm1Brn/Trp53tm1Brn
Tg(Wap-cre)51Nki/0
(involves: 129P2/OlaHsd * FVB/N) 		increased mammary adenocarcinoma incidence J:171765
Trp53tm1Elee/Trp53tm1Elee
Tg(MMTV-cre)AElee/0
(involves: 129S4/SvJae * C57BL/6) 		increased mammary adenocarcinoma incidence J:90247
Trp53tm1Elee/Trp53tm1Elee
Tg(MMTV-cre)BElee/0
(involves: 129S4/SvJae * C57BL/6) 		increased mammary adenocarcinoma incidence J:90247
Trp53tm1Elee/Trp53tm1Elee
Tg(Wap-rtTA-cre)10Whl/0
(involves: 129S4/SvJae * C57BL/6) 		increased mammary adenocarcinoma incidence J:90247
Trp53tm1Glo/Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased adenocarcinoma incidence J:171821
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased adenocarcinoma incidence J:72391
increased lung adenocarcinoma incidence J:72391
increased mammary adenocarcinoma incidence J:72391
Trp53tm1Tyj/Trp53+
Trp63tm1Fmc/Trp63+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased mammary adenocarcinoma incidence J:98958
Trp53tm1Tyj/Trp53+
Trp73tm1Fmc/Trp73+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased lung adenocarcinoma incidence J:98958
increased pancreatic acinar cell carcinoma incidence J:98958
Trp53tm3.1Glo/Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased adenocarcinoma incidence J:171821
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae) 		increased lung adenocarcinoma incidence J:95316
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae * SKH1) 		increased mammary adenocarcinoma incidence J:121734
Trp53tm3Tyj/Trp53+
Tg(Wap-cre)11738Mam/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		increased mammary adenocarcinoma incidence J:101617
Trp53tm4Glo/Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased adenocarcinoma incidence J:171821
Trp63tm1Fmc/Trp63+
Trp73tm1Fmc/Trp73+
(involves: 129S4/SvJae * C57BL/6) 		increased lung adenocarcinoma incidence J:98958
increased mammary adenocarcinoma incidence J:98958
Trp73tm1Fmc/Trp73+
(involves: 129S4/SvJae * C57BL/6) 		increased lung adenocarcinoma incidence J:98958
Trp73tm1Fmc/Trp73tm1Fmc
(involves: 129S4/SvJae * C57BL/6) 		increased lung adenocarcinoma incidence J:98958
Trp73tm1Mak/Trp73+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lung adenocarcinoma incidence J:142848
Trp73tm1Mak/Trp73tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lung adenocarcinoma incidence J:142848
Vhltm1.1Wkr/Vhl+
(involves: 129S4/SvJae * C57BL/6) 		increased adenocarcinoma incidence J:157369
Xpatm1Tnka/Xpatm1Tnka
(involves: C57BL/6 * CBA) 		increased lung adenocarcinoma incidence J:62877
Xpctm1Ecf/Xpctm1Ecf
(involves: 129 * C57BL/6) 		increased lung adenocarcinoma incidence J:101421
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
12/10/2024
MGI 6.24 		The Jackson Laboratory